First test of A3-Shield device for belly artery bulge
Part of Heart & circulation clinical trials.
This trial tests a new device called the A3-Shield that is placed inside the belly's main artery to support a bulging area (aneurysm) and keep it from growing or bursting. It may be an option for patients whose aneurysm is large enough but not yet causing symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a bulge (aneurysm) in the main belly artery that is between about 3 and 5 cm wide (slightly smaller for women).
- Your blood vessels in the groin must be wide enough for the delivery tube (14 French).
- You must be able to come back to the hospital for follow-up visits.
- You cannot have a ruptured or painful aneurysm, a weak connective tissue disease, or other serious health problems like recent heart attack or stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special device called the TREO stent graft to treat abdominal aortic aneurysms (a widened artery in the belly). It repairs the aneurysm from inside the blood vessel instead of open surgery, which may mean a faster recovery.
This trial tests a new device (Nectero EAST) for treating abdominal aortic aneurysms without major surgery. It may be an option for people with a medium-size aneurysm who have not had prior repair.
This trial tests a new multibranched stent graft system to treat thoracoabdominal aortic aneurysms. It may help patients who have an aneurysm that is large, growing quickly, or causing symptoms like pain.
This study is testing a new approach to manage abdominal aortic aneurysms (bulges in the main belly artery). It is for people whose aneurysm is larger than 30 mm but does not have certain rare features that require different care.
This trial tests a specialized stent (a small mesh tube) placed inside the chest and belly aorta to treat a thoracoabdominal aortic dissecting aneurysm. It may help prevent the artery from getting bigger or causing dangerous bleeding by supporting the weakened area from inside.
This trial tests a new device that blocks blood flow into brain aneurysms (balloon-like bulges in blood vessels). It is for patients with a specific type of unruptured or recently ruptured aneurysm, located in three common places in the brain, that has a wide neck.
Hear when a new Aneurysm, Abdominal Aortic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.